Summit Therapeutics Inc

SMMT NASDAQ Healthcare & Biotech United States US86627T1088
15.01 $
0.60 %

Summit Therapeutics is a biopharmaceutical company focused on developing new antibiotic treatments for resistant bacterial infections and other serious diseases.